Faculty of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France; AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital Bicêtre, DMU 5 Thorinno, Le Kremlin-Bicêtre, France; INSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis Robinson, France; University of Calgary, Calgary, AB, Canada.
AP-HP, Département de Génétique, Hôpital Pitié-Salpêtrière UMR_S 1166 Sorbonne Université, Paris, France.
Chest. 2023 Aug;164(2):e23-e26. doi: 10.1016/j.chest.2023.04.031. Epub 2023 Apr 23.
Heritable pulmonary arterial hypertension (PAH) is an uncommon cause of PAH and is associated most frequently with pathogenic variants of BMPR2. Prior studies have described abnormalities in pulmonary arterial, venous, and bronchial artery vessels associated with these pathogenic variants. In this series, we describe two patients who demonstrated pulmonary arteriovenous malformations (AVMs) and incidentally were identified by a next generation sequencing gene panel to carry variants of BMPR2 in the absence of PAH. Although pulmonary AVMs commonly are associated with hereditary hemorrhagic telangiectasia and rarely are seen in heritable PAH, evidence is increasing that abnormalities in the BMP9 pathway are found in both of these conditions. Through these cases and the current understanding of the BMP9 pathway, we propose that BMPR2 variants place patients at increased risk of pulmonary AVMs and may warrant screening.
遗传性肺动脉高压 (PAH) 是 PAH 的一种罕见病因,最常与 BMPR2 的致病性变异相关。先前的研究已经描述了与这些致病性变异相关的肺动脉、静脉和支气管动脉血管的异常。在本系列中,我们描述了两名患者,他们表现出肺动静脉畸形 (AVM),并且偶然通过下一代测序基因面板在没有 PAH 的情况下携带 BMPR2 的变异。尽管肺 AVM 通常与遗传性出血性毛细血管扩张症相关,并且在遗传性 PAH 中很少见,但越来越多的证据表明,BMP9 通路的异常存在于这两种情况下。通过这些病例和对 BMP9 通路的现有理解,我们提出 BMPR2 变异使患者发生肺 AVM 的风险增加,可能需要进行筛查。